The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing
- DOI
- 10.3390/pharmaceutics18091132
- Published
- 2026-09-09
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18091132,
title = {The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing},
author = {Zofia Śledzikowska and Karolina Żylińska and Natalia Makaruk and Dominika Kubicka and Filip Adam Błotniak and Napoleon Waszkiewicz},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18091132},
url = {https://doi.org/10.3390/pharmaceutics18091132}
}RIS
TY - JOUR TI - The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing AU - Zofia Śledzikowska AU - Karolina Żylińska AU - Natalia Makaruk AU - Dominika Kubicka AU - Filip Adam Błotniak AU - Napoleon Waszkiewicz PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18091132 UR - https://doi.org/10.3390/pharmaceutics18091132 ER -
APA
Śledzikowska, Z., Żylińska, K., Makaruk, N., Kubicka, D., Błotniak, F. A., & Waszkiewicz, N. (2026). The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18091132
Source records
- crossref · retrieved 2026-09-26T15:33:30.445Z